Table 2.
References | Location | Number of points examined | Period of examination | Samples Positive (total number of samples) | Ct value |
---|---|---|---|---|---|
Or et al. (2020) | Israel | 17 | 10/03/2010−21/04/2020 | 10 (26) | 32.76−38.5 |
Wu et al. (2020a) | U.S.A. (Massachusetts) | 2 | 08/01/2020−25/03/2020 | 10 (12) | 33.87−38.39 |
Rimoldi et al. (2020) | Italy | 3 | 14/04/2020−22/04/2020 | 4 (12) | n.a. |
Ahmed et al. (2020) | Australia | 3 | 20/03/2020−01/04/2020 | 2 (9) | 37.5−39a |
Medema et al. (2020) | Netherlands | 7 | 05/02/2020−16/03/2020 | 14 (24) | n.a. |
Randazzo et al. (2020a) | Spain | 3 | 12/02/2020−14/04/2020 | 13 (15) | 34.00–37.84 |
Randazzo et al. (2020b) | Spain | 6 | 12/03/2020−14/04/2020 | 37 (72) | 34.00–40.00 |
Wurtzer et al. (2020) | France | 3 | 05/03/2020−23/04/2020 | 100 % of samples positiveb | n.a. |
La Rosa et al. (2020b) | Italy | 4 | 03/02/2020−02/04/2020 | 6 (12) | n.a. |
Kocamemi et al. (2020a) | Turkey | 9 | 21/04/2020−25/04/2020 | 7 (9) | 34.67−39.54 a |
Kumar et al. (2020) | India | 1 | 08/05/2020−27/05/2020 | 2 (2) | 32.65−39.56 |
Arora et al. (2020) | India | 8 | 04/05/2020−12/06/2020 | 6 (17) | 5.19–37.52 |
Balboa et al. (2020) | Spain | 1 | 06/04/2020−21/04/2020 | 7 (7) | 33.61−39.60 |
Haramoto et al. (2020) | Japan | 1 | 17/03/2020−07/05/2020 | 0 (5) | n.a. |
Green et al. (2020) | U.S.A. (New York) | 11 | 06/05/2020 – 13/05/2020 | 18 (22) | n.a. |
n.a.: not available.
aExpressed as Cq.
bTotal number of samples not available.